US Stock MarketDetailed Quotes

CLNNW CLENE INC C/WTS 07/11/2025 (TO PUR COM)

Watchlist
  • 0.0390
  • -0.0030-7.14%
Close May 28 16:00 ET
0Market Cap0.00P/E (TTM)

About CLENE INC C/WTS 07/11/2025 (TO PUR COM) Company

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Company Profile

SymbolCLNNW
Company NameCLENE INC C/WTS 07/11/2025 (TO PUR COM)
Listing DateAug 27, 2018
Founded2013
CEOMr. Robert Etherington
MarketNASDAQ
Employees85
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address6550 South Millrock Drive,Suite G50
CitySalt Lake City
ProvinceUtah
CountryUnited States of America
Zip Code84121
Phone1-801-676-9695
Websitehttp://www.clene.com

Company Executives

  • Name
  • Position
  • Salary
  • Robert Etherington
  • President, Chief Executive Officer and Director
  • 1.71M
  • Morgan R. Brown
  • Chief Financial Officer and Principal Accounting Officer
  • 993.70K
  • Mark Mortenson
  • Chief Science Officer
  • 1.38M
  • David J. Matlin
  • Chairman of the Board
  • 139.93K
  • Reed Neil Wilcox
  • Director
  • --
  • Matthew Kiernan
  • Independent Director
  • --
  • Alison H. Mosca
  • Independent Director
  • 123.39K
  • Shalom Jacobovitz
  • Independent Director
  • 121.93K
  • Jonathon T. Gay
  • Independent Director
  • 96.13K
  • Dr. Vallerie V. McLaughlin
  • Independent Director
  • 106.84K
  • Dr. Arjun JJ Desai, M.D.
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg